IDEAYA Biosciences and Servier Present Promising Darovasertib Data for Uveal Melanoma at ESMO 2026 #USA #South_San_Francisco #uveal_melanoma #darovasertib #ESMO_2026
third-news.comIDEAYA Biosciences and Servier Present Promising Darovasertib Data for Uveal Melanoma at ESMO 2026Highlighting the potential of darovasertib, IDEAYA alongside Servier presented significant data at ESMO 2026 for treating uveal melanoma across various patient groups.
